Concurrent TMS/fMRI reveals individual DLPFC dose-response pattern

Background: TMS is a valuable tool in both research and clinical settings, playing a crucial role in understanding brain-behavior relationships and providing treatment for various neurological and psychiatric conditions. Importantly, TMS over left DLPFC is an FDA approved treatment for MDD. Despite...

Full description

Bibliographic Details
Main Authors: Martin Tik, Maria Vasileiadi, Michael Woletz, David Linhardt, Anna-Lisa Schuler, Nolan Williams, Christian Windischberger
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:NeuroImage
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1053811923005451